Cover Image
市場調查報告書

全球臨床營養產品市場

Clinical Nutrition Products

出版商 Global Industry Analysts, Inc. 商品編碼 121181
出版日期 內容資訊 英文 387 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球臨床營養產品市場 Clinical Nutrition Products
出版日期: 2017年02月01日 內容資訊: 英文 387 Pages
簡介

本報告提供全球臨床營養產品市場相關調查,提供市場概要與今後預測,各地區趨勢,及加入此市場的主要企業簡介。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 臨床營養產品:解決與疾病相關的營養不良的基本要素
    • 市場預測
    • 已開發國家領先但新興市場推動未來的成長
    • 嬰幼兒營養市場:高增長潛力的領先優勢
    • 需要營養支持
    • 不合適的生理學發展
    • 早產兒的營養需求
    • 非口服營養
    • 亞太地區推動未來的成長
    • 經腸營養
    • 標準的經腸營養
    • 腫瘤學的應用
    • 醫院及長期療養設施
  • 競爭環境
    • 競爭激烈的市場
    • 經腸營養市場
    • 非口服營養市場
  • 市場趨勢,推動成長要素,技術進步
  • 產品概要
    • 臨床營養:簡介
    • 暗示臨床營養給藥的疾病
    • 臨床營養的優點
    • 臨床營養產品的分類
    • 幼兒營養產品
    • 經腸營養產品
    • 非口服營養
  • 產品創新/引進
  • 近幾年的產業活動
  • 全球主要加入企業
    • Abbott Nutrition
    • Baxter International, Inc.
    • B. Braun Melsungen AG
    • Claris Lifesciences Ltd.
    • Claris Otsuka Private Ltd
    • Fresenius Kabi AG
    • Groupe Danone
    • Nutricia North America
    • Huarui Pharmaceutical Co., Ltd.
    • ICU Medical, Inc.
    • Mead Johnson Nutrition Company
    • 株式會社明治
    • Nestle Health Science S.A
    • 大塚製藥株式會社
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 中東·非洲
  • 南美

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6353

This report analyzes the worldwide markets for Clinical Nutrition Products in US$ Million. The Global market is analyzed by the following segments: Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 65 companies including many key and niche players such as -

Abbott Nutrition
Baxter International, Inc.
B. Braun Melsungen AG
Claris Lifesciences Ltd.
Fresenius Kabi AG

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • 1. Enteral Nutrition
    • 2. Infant Nutrition
    • 3. Parenteral Nutrition

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Clinical Nutrition Products: Essential for Addressing Disease-Related Malnutrition
  • Market Outlook
  • Developed Regions Lead, Emerging Markets to Spearhead Future Growth
  • Infant Nutrition Market: The Leading Segment with High Growth Potential
    • Table 1: Global Infant Nutrition Market (2016): Percentage Breakdown of Value Sales by Segment - Dried Food, Follow-On Formula, Prepared Food, Special Formula, Standard Formula and Toddler Formula (includes corresponding Graph/Chart)
  • Need for Nutritional Support - Essential for Preterm Infants
  • Inadequate Physiological Development Raises Need for Tube Feeding in Infants
  • Nutritional Needs of Premature Infants: Mix of PN & EN Nutrition Emerges as Common Practice
  • Parenteral Nutrition: Providing Essential Nutrition through Intravenous Feeding
    • Table 2: Global Parenteral Nutrition Products Market (2016): Percentage Breakdown of Revenues by Product Category (includes corresponding Graph/Chart)
  • Asia-Pacific to Drive Future Growth in PN Products Market
  • Enteral Nutrition - Preferred Approach Compared to Parenteral Nutrition Products
  • Standard Enteral Nutrition Formulations Lead EN Products Market
    • Table 3: Global Enteral Nutrition Products Market by Product Type (2016): Percentage Breakdown of Revenues for Disease-Specific Products and Standard Products (includes corresponding Graph/Chart)
  • Oncology Applications Leads EN Market
  • Hospitals & Long-term Care Facilities: The Major Users of EN Products

2. COMPETITIVE LANDSCAPE

  • A Highly Competitive Marketplace
    • Table 4: Leading Players in the Global Clinical Nutrition Market (2016E): Percentage Breakdown of Value Sales for Abbott Nutrition, Danone, Fresenius Kabi, Nestle and Others (includes corresponding Graph/Chart)
    • Table 5: Leading Manufacturers in the Global Infant Nutrition Market (2016E): Percentage Breakdown of Revenues for Abbott Nutrition, Danone, Mead Johnson, Nestle and Others (includes corresponding Graph/Chart)
  • Enteral Nutrition Market
    • Table 6: Leading Manufacturers in the Global Enteral Nutrition Market (2016E): Percentage Breakdown of Revenues for Abbott, Danone, Fresenius Kabi, Mead Johnson, Nestle and Others (includes corresponding Graph/Chart)
  • Parenteral Nutrition Market
    • Table 7: Leading Manufacturers in the Global Parenteral Nutrition Market (2016E): Percentage Breakdown of Revenues for B. Braun, Baxter International, Fresenius Kabi, ICU Medical and Others (includes corresponding Graph/Chart)

3. MARKET DRIVERS, TRENDS & ISSUES

  • Sustained Increase in Healthcare Spending Bodes Well for Clinical Nutrition Market
    • Table 8: Healthcare Spending as % of GDP by Geographic Region (2016) (includes corresponding Graph/Chart)
    • Table 9: Top Countries with the Highest Per Capita Healthcare Spending (2014) (includes corresponding Graph/Chart)
  • Aging Worldwide Population: Rising Need for Added Nutritional Support to Propel Market Growth
    • Table 10: Global Aging Population in Select Regions/ Countries: Population of 60+ Individuals in '000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)
    • Table 11: Elderly Population (60+ Years) as a Percentage of Total Population (2015 & 2050) (includes corresponding Graph/Chart)
    • Table 12: Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
  • Rising Incidence of Chronic Diseases to Kindle Market Growth
  • Cancer - The Major Chronic Illness Requiring Clinical Nutrition Support
    • Table 13: Worldwide Incidence of Cancer: Number of New Cases Diagnosed for the Years 2013, 2020 & 2030 (includes corresponding Graph/Chart)
    • Table 14: New Cancer Cases in the World by Affected Site (2012) (In Thousands) (includes corresponding Graph/Chart)
    • Table 15: Common Cause of Cancer Deaths Worldwide - Number of Deaths due to Select Types of Cancer for 2015 (includes corresponding Graph/Chart)
  • Critical Nutrition Products Vital for Preventing Malnutrition in Diabetics
    • Table 16: Diabetes Prevalence Worldwide by Region: Number of Adults (20-79 Years) with Diabetes in 2015 and 2040 (includes corresponding Graph/Chart)
    • Table 17: Global Prevalence (%) of Diabetes in Adults (20-79) by Region: 2015 & 2040 (includes corresponding Graph/Chart)
    • Table 18: Global Prevalence of Diabetes by Gender (2015 & 2040): Number of Adults Diagnosed with Diabetes (in Million) for Men and Women (includes corresponding Graph/Chart)
    • Table 19: Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2015 & 2040 (includes corresponding Graph/Chart)
  • Persistent Threat of HIV/AIDS Infection: An Opportunity for Medical Nutrition Market
    • Some Significant HIV Statistics by Region: 2015
    • Table 20: Global Prevalence of HIV Infection in 2015 by Region (in Millions) (includes corresponding Graph/Chart)
    • Table 21: New HIV Infections Worldwide by Geographic Region for 2015 (in Thousands) (includes corresponding Graph/Chart)
    • Table 22: Global AIDS-Related Deaths by Geographic Region for the Year 2015 (includes corresponding Graph/Chart)
  • Clinical Nutrition in Treatment of Malnutrition: Significant Growth Opportunities
  • Non-volitional Nutritional Support Therapy: Vital for Combating Malnutrition during Hospitalization
  • Shift towards Home Care Boosts Demand for Clinical Nutrition Products
    • Table 23: Trend towards Home Healthcare to Propel Home Clinical Nutrition Market - Global Home Healthcare Revenues (in US$ Billion) for the Years 2016, 2018 & 2020 (includes corresponding Graph/Chart)
  • Changing Health and Social Care Factors Favor Home Enteral Feeding
  • Rising Number of Premature Births Drives Infant Clinical Nutrition Products Market
  • Preterm Birth Statistics from WHO
    • Table 24: Percentage of Preterm Births by Region: 2012 (includes corresponding Graph/Chart)
    • Table 25: Top Ten Countries with the Highest Number of Preterm Births (2012) (includes corresponding Graph/Chart)
    • Table 26: Top Ten Countries with the Highest Rates of Preterm Births (per 100 Live Births): 2012 (includes corresponding Graph/Chart)
  • Demand for Personalized Medicine to Bode Well for Clinical Nutrition Products Market
  • Product Innovations Blur the Lines between Medicine and Foods
  • Surging Demand for Omega-3 Fatty Acids-Fortified Clinical Nutrition Products
  • Advances in Enteral Feeding Devices: Positive Outlook for Enteral Nutrition Market
  • Rising Incidence of Pediatric Crohn's Disease Fuels Enteral Nutrition Market
  • Specialized Formula Products Inundate the Market
  • Soy-based Infant Formula Gains Popularity
  • Pre-mixed IV Solutions: A Step towards Safer Medication Practices
  • Growing Demand for Low-Cost Parenteral Nutrition Solutions
  • Rising Preference for Multi-Chamber Bags to Lower Cost of Parenteral Nutrition Therapy
  • Increasing Popularity of Intravenous Vitamin C for Cancer Treatment
  • Infection Control: A Prime Concern in Parenteral Nutrition
  • Complacency of Hospitals & Worker/Patient Safety: A Key Issue
  • Favorable Clinical Findings Strengthens Prospects for Enteral Nutrition
  • Rising Preference for Enteral Nutrition - A Threat to Parenteral Nutrition Market
  • Advantages and Disadvantages of Enteral Nutrition over Parenteral Nutrition
  • Major Challenges Confronting Medical Nutrition Products' Marketers
  • Barriers to Widespread Adoption of Clinical Nutrition Products
  • Reasons for Not Prescribing Clinical Nutrition Products

4. PRODUCT OVERVIEW

  • Clinical Nutrition: An Introduction
  • Diseases Indicating Administering of Clinical Nutrition
  • Advantages of Clinical Nutrition
  • Classification of Clinical Nutrition Products
  • Infant Nutrition Products
    • Table 27: Nutrient Specifications for Infant Formulas (per 100kcal)
    • List of Infant Nutrition Products
    • Types of Infant Nutrition Products
      • Specialized Milk-Based Formulas
      • Soy-based Infant Formula
      • Amino Acid-based Formulas
      • Probiotic Infant Formulas
      • Prebiotics in Infant Nutrition
      • Exempt Infant Formulas
      • Human Milk Oligosaccharides
      • Nutrition Products for Preterm Infants
      • Premature Infant Formula
      • Transitional Formulas
      • Human Milk Fortifiers
      • Metabolic Infant Formulas
      • Follow-up or Follow-on Formulas
      • Enteral Administration of Infant Formulas in Neonatal Intensive Care and General Healthcare Settings
      • Nipple Feeding
      • Tube Feeding
  • Enteral Nutrition Products
    • Table 28: Daily Electrolyte Requirements for Enteral Nutrition
    • Table 29: Daily Trace Element Requirement for Enteral Nutrition
    • Table 30: Daily Vitamin Requirements for Enteral Nutrition
    • Table 31: Daily Trace Element Requirements Enteral Nutrition in Infants
    • Table 32: Daily Vitamin Requirements for Enteral Nutrition in Infants
    • Enteral Nutrition by Age
      • Enteral Nutrition for Patients aged 21 and older
      • Enteral Nutrition for Patients below 21 Years
      • Various Types of Enteral Feeding or Tube Feeding
    • What Constitutes Enteral Nutrition Diets?
      • Home-Made Diets
      • Commercial Enteral Formulas
      • Elemental Formulas
      • Oligomeric Formulas
      • Polymeric Formulas
      • Special Formulas
      • Pulmonary Formulas
      • Liver Formulas
      • Renal Formulas
      • Diabetes Formulas
      • Gastrointestinal Dysfunction Formulas
      • Immuno-modulatory Formulas
    • Enteral Nutrition in Patients with Acute Renal Failure (ARF)
    • Table 33: Nutritional Requirements in Patients with ARF
    • Enteral Nutrition in Conservatively Treated Patients with Chronic Renal Failure (CRF)
    • Table 34: Recommendations for Protein Supply in Adult CRF Patients (in g/kgBW/day)
    • Table 35: Mineral Requirements for Patients with CRF
    • Enteral Nutrition in Haemodialysis Patients
    • Enteral Nutrition in Chronic Ambulatory Peritoneal Dialysis (CAPD) Patients
    • Table 36: Recommendations for Protein and Energy Supply in Adult Patients on Routine Hemodialysis and CAPD
    • Table 37: Mineral Requirements of Patients on Haemodialysis and Chronic Ambulatory Peritoneal Dialysis
    • Complications of Enteral Feeding
      • Complications Associated with Enteral Tube Feeding
  • Parenteral Nutrition
    • Sources of Parenteral Solutions
    • Routes of Administration
    • Types of Parenteral Nutrition Solutions
      • Total Parenteral Nutrition (TPN)
    • Table 38: Daily Requirements for Total Parenteral Nutrition (TPN) in Adults
    • Table 39: Daily Recommended Parenteral Nutritional Intakes for Newborns
      • TPN Formulation
      • Partial Parenteral Nutrition (PPN)
      • Home Parenteral Nutrition
    • Parenteral Nutrition Formulations
      • Standard Solutions
      • Three-in-One Standard Bags
      • Two-in-one Standard Bags
      • Individual Solutions
      • Non-Standard Solutions
    • Classification of Parenteral Nutrition by Type of Nutrients
      • Amino Acids
      • Carbohydrates
      • Lipids
      • Minerals & Electrolytes
    • Table 40: Daily Electrolyte Requirements for Parenteral Nutrition
      • Micronutrients
      • Vitamins
    • Table 41: Daily Vitamin Requirements for Parenteral Nutrition
      • Trace Elements
    • Table 42: Daily Trace Element Requirement for Parenteral Nutrition
    • Large and Small Volume Parenteral Solutions
      • Large Volume Parenteral (LVP) Solutions
      • Small Volume Parenteral (SVP) Solutions
    • IV Fat Emulsions - Enabling Maintenance of Bodyweight

5. PRODUCT INNOVATIONS/INTRODUCTIONS

  • Nestle Health Science Introduces Compleat(r) Range of Tube-Feeding Formulas
  • Fresenius Kabi Unveils IVFE Smoflipid(r) for Adults
  • Otsuka Pharmaceutical Factory Gains Approval for ELNEOPA-NF Injection
  • B. Braun Medical Unveils Clinical Nutrition 360 TPN Portfolio
  • B. Braun Medical Introduces Nutrilipid(r) 20% for Parenteral Nutrition Therapy
  • Otsuka Introduces HINE E-GEL Concentrated Liquid Nutrition Product
  • Fresenius Kabi Obtains FDA Approval for Perikabiven(r) and Kabiven(r)
  • B. Braun Obtains FDA Approval for Nutrilipid(r) 20% for Parenteral Nutrition

6. RECENT INDUSTRY ACTIVITY

  • ICU Medical Acquires Pfizer's Hospira Infusion Therapy Business
  • OP2Labs Acquires Provide Nutrition
  • Abbott and Vietnam's Ministry of Health Forge Strategic Partnership
  • Baxter International Gains Marketing Approval for NUMETA G13E PN Product
  • Nestle Japan Acquires Ajinomoto's Tube Feeding Business
  • Linde Group Takes Over American HomePatient
  • Epic Health Services Takes Over Option 1 Healthcare Solutions
  • Baxter Inks Global Licensing and Distribution Agreement with Laboratoire Aguettant
  • Pfizer Acquires Hospira
  • Nestle Sets Up Health Science Manufacturing Plant
  • Baxter Recalls Select Lots of Parenteral Nutrition Products
  • ITH Pharma Recalls Lipid Phase Parenteral Nutrition Products
  • Abbott Receives Approval for ENEVO(tm) Liquid for Enteral Use
  • Nestle to Construct Infant Formula Plant in Mexico
  • Abbott Inaugurates Nutrition Production Facility in Haiti
  • Baxter Recalls Select Lots of Premix Parenteral Nutrition Products
  • Baxter Collaborates with JW Holdings for Omega 3 Lipids
  • Mead Johnson Establishes New Manufacturing and Research & Development Complex

7. FOCUS ON SELECT GLOBAL PLAYERS

  • Abbott Nutrition (US)
  • Baxter International, Inc. (US)
  • B. Braun Melsungen AG (Germany)
  • Claris Lifesciences Ltd. (India)
  • Claris Otsuka Private Ltd. (India)
  • Fresenius Kabi AG (Germany)
  • Groupe Danone (France)
  • Nutricia North America (US)
  • Huarui Pharmaceutical Co., Ltd. (China)
  • ICU Medical, Inc. (US)
  • Mead Johnson Nutrition Company (US)
  • Meiji Co., Ltd. (Japan)
  • Nestle Health Science S.A (Switzerland)
  • Otsuka Pharmaceutical Factory, Inc. (Japan)

8. GLOBAL MARKET PERSPECTIVE

    • Table 43: World Recent Past, Current and Future Analysis for Clinical Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 44: World Historic Review for Clinical Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 45: World 14-Year Perspective for Clinical Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 46: World Recent Past, Current and Future Analysis for Enteral Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 47: World Historic Review for Enteral Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 48: World 14-Year Perspective for Enteral Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 49: World Recent Past, Current and Future Analysis for Infant Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 50: World Historic Review for Infant Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 51: World 14-Year Perspective for Infant Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 52: World Recent Past, Current and Future Analysis for Parenteral Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 53: World Historic Review for Parenteral Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 54: World 14-Year Perspective for Parenteral Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Market Overview
    • Aging Population Fuels Need for Clinical Nutrition
    • Table 55: Aging Population in the US (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
    • Rising Incidences of Chronic Diseases Heightens Need for Clinical Nutrition Products
      • Cancer Statistics in the US
    • Table 56: Estimated Number of New Cancer Cases in the US by State for 2017 (includes corresponding Graph/Chart)
    • Table 57: Estimated Number of New Cancer Cases in the US by Gender and Affected Site for 2017 (includes corresponding Graph/Chart)
    • Table 58: Estimated Number of Cancer-Related Deaths in the US by Gender and Body Site for 2017 (includes corresponding Graph/Chart)
      • Rising Prevalence of Diabetes Mellitus in North America
    • Table 59: Diabetes and Population Statistics in North America and Caribbean Region (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 60: Diabetes Statistics in the US (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) (includes corresponding Graph/Chart)
    • An Insight into Infant Nutrition Market
    • Table 61: Infant & Toddler Nutrition Market in the US (2016): Percentage Breakdown of Value Sales by Segment (includes corresponding Graph/Chart)
      • Clinical Nutrition - Vital for Preterm Infants
    • Table 62: Preterm Birth Rate (%) in the US by State for 2015
    • Table 63: Preterm Birth Rate (%) in the US by Race/Ethnicity for 2014 and 2015 (includes corresponding Graph/Chart)
    • Table 64: Preterm Birth Rate (%) in the US by Gestational Age for 2014 and 2015 (includes corresponding Graph/Chart)
      • Strategic Innovations to Buoy Consumer Demand
      • Human Breast Milk-Like Infant Formulas to Gain Popularity
      • Competition
    • Table 65: Leading Players in the US Infant Formula Market (2016): Percentage Breakdown of Value Sales for Abbott, Mead Johnson, Nestle, and Others (includes corresponding Graph/Chart)
    • Enteral Nutrition Market: Aging Population to Stimulate Growth
      • Home Healthcare Fuels Demand for Home Enteral Nutrition Products
      • Enteral Nutrition Therapy to Treat Adult Malnutrition: Opportunities for Growth
      • Reimbursement Scenario for Enteral Nutrition Therapy
      • ENT Coverage under Part A
      • ENT Coverage under Part B
      • Reimbursements for Enteral Nutrients
    • Parenteral Nutrition Market: An Overview
      • Medicare Coverage for Parenteral Nutrition Therapy
      • Reimbursement Regulations to Hamper Market Growth
      • Shift towards Enteral Nutrition Therapies - A Threat to Parenteral Nutrition Market
      • Advantages and Disadvantages of Enteral Nutrition over Parenteral Nutrition
      • A.S.P.E.N. Practice Guidelines for Parenteral Nutrition
      • A.S.P.E.N. Guidelines for Parenteral Nutrition (as of 2004)
    • Product Launches
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 66: US Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 67: US Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 68: US 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current and Future Analysis
    • Rising Incidence of Chronic Diseases: A Major Growth Driver
    • Table 69: New Cancer Cases (in Thousands) in Canada by Gender for 2015 and 2016 (includes corresponding Graph/Chart)
    • Table 70: Age-Standardized Incidence Rate (Per '000 People) in Canada by Gender and Type of Cancer - 2016 (includes corresponding Graph/Chart)
    • Table 71: New Cancer Cases in Canada by Gender and Affected Site for 2016 (includes corresponding Graph/Chart)
    • Table 72: New Cancer Cases in Canada by Province for 2016 (includes corresponding Graph/Chart)
    • Table 73: New Cancer Cases in Canada by Age Group for 2016 (includes corresponding Graph/Chart)
    • Table 74: Cancer Related Deaths in Canada by Gender and Affected Site for 2016 (includes corresponding Graph/Chart)
    • Table 75: Cancer Related Deaths in Canada by Age Group for 2016 (includes corresponding Graph/Chart)
    • Table 76: Diabetes Statistics in Canada (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) (includes corresponding Graph/Chart)
    • Table 77: Aging Population in Canada (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 78: Canadian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 79: Canadian Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 80: Canadian 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Market Overview
    • Rising Incidence of Chronic Diseases - A Prime Growth Driver
    • Table 81: Cancer Incidence and Number of Cancer-Related Deaths among Japanese Men and Women for 2015 (includes corresponding Graph/Chart)
    • Table 82: Diabetes Statistics in Japan (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in '000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in '000s), and Number of Children with Type 1 diabetes (in '000s) (includes corresponding Graph/Chart)
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 83: Japanese Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 84: Japanese Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 85: Japanese 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Market Overview
    • An Overview of Enteral Feeding Market in Europe
      • Prospering Enteral Nutrition Market: New Avenues for Ingredient Suppliers
      • Surging Interest in Home Healthcare: Gains for Enteral Nutrition Market
    • Aging Population & Rising Incidence of Chronic Diseases to Spur Growth
      • Aging Statistics
    • Table 86: Aging Population in Europe by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
    • Table 87: Aging Population in Europe by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
      • Cancer Trends
    • Table 88: Number of New Cancer Cases in Europe (2012-2030) (In Million) (includes corresponding Graph/Chart)
    • Table 89: Cancer Incidence in Europe by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
      • Prevalence of Diabetes Mellitus in Europe
    • Table 90: Diabetes and Population Statistics in Europe (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 91: Diabetes Statistics in Europe (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 92: European Recent Past, Current and Future Analysis for Clinical Nutrition Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 93: European Historic Review for Clinical Nutrition Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 94: European 14-Year Perspective for Clinical Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 95: European Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 96: European Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 97: European 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current and Future Analysis
    • An Insight into Enteral Nutrition Market
    • Strategic Corporate Development
    • Groupe Danone - A Key Player
  • B. Market Analytics
    • Table 98: French Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 99: French Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 100: French 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Market Overview
    • Strategic Corporate Development
    • Key Players
  • B. Market Analytics
    • Table 101: German Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 102: German Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 103: German 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 104: Italian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 105: Italian Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 106: Italian 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current and Future Analysis
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 107: UK Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 108: UK Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 109: UK 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 110: Spanish Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 111: Spanish Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 112: Spanish 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 113: Russian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 114: Russian Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 115: Russian 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Current and Future Analysis
    • Nestle Health Science S.A (Switzerland) - A Key Player
  • B. Market Analytics
    • Table 116: Rest of Europe Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 117: Rest of Europe Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 118: Rest of Europe 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Market Overview
    • Rising Cases of Diabetes Mellitus: Opportunity for Clinical Nutrition Market in Asia-Pacific
    • Table 119: Diabetes and Population Statistics in Western Pacific (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 120: Diabetes Statistics in Western Pacific (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
    • Table 121: Diabetes and Population Statistics in South East Asia (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 122: Diabetes Statistics in South East Asia (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 123: Asia-Pacific Recent Past, Current and Future Analysis for Clinical Nutrition Products by Geographic Region - Australia, China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 124: Asia-Pacific Historic Review for Clinical Nutrition Products by Geographic Region - Australia, China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 125: Asia-Pacific 14-Year Perspective for Clinical Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for Australia, China, India and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 126: Asia-Pacific Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 127: Asia-Pacific Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 128: Asia-Pacific 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5a. AUSTRALIA

  • A. Market Analysis
    • Current and Future Analysis
    • Home Enteral Nutrition in New South Wales
  • B. Market Analytics
    • Table 129: Australian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 130: Australian Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 131: Australian 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5b. CHINA

  • A. Market Analysis
    • Market Overview
    • Parenteral Nutrition Market: An Insight
    • Competitive Scenario
    • Table 132: Leading Suppliers of Enteral Nutrition Preparations in China (2015): Percentage Breakdown of Value Sales for Huarui Pharmaceutical, Nutricia and Others (includes corresponding Graph/Chart)
    • Huarui Pharmaceutical Co., Ltd. - A Key Player
  • B. Market Analytics
    • Table 133: Chinese Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 134: Chinese Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 135: Chinese 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5c. INDIA

  • A. Market Analysis
    • Current and Future Analysis
    • Ready-to-Use Therapeutic Food to Treat Severe Acute Malnutrition in India
    • Table 136: Percentage Share Breakdown of Cost Composition of Ingredients Required for the Production of RUTF (includes corresponding Graph/Chart)
    • Key Players
  • B. Market Analytics
    • Table 137: Indian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 138: Indian Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 139: Indian 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5d. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Current and Future Analysis
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 140: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 141: Rest of Asia-Pacific Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 142: Rest of Asia-Pacific 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

6. MIDDLE EAST & AFRICA

  • A. Market Analysis
    • Current and Future Analysis
    • Increasing Incidence of Chronic Conditions: Positive Growth Prospects
    • Table 143: Diabetes and Population Statistics in Middle East and North Africa (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 144: Diabetes Statistics in Middle East and North Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
    • Table 145: African Diabetes and Population Statistics (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 146: Diabetes Statistics in Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 147: Middle East & Africa Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 148: Middle East & Africa Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 149: Middle East & Africa 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

7. LATIN AMERICA

  • A. Market Analysis
    • Current and Future Analysis
    • Rising Incidence of Diabetes in Latin America - Opportunity Indicator
    • Table 150: Diabetes Statistics in South & Central America (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 151: Latin American Recent Past, Current and Future Analysis for Clinical Nutrition Products by Geographic Region - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 152: Latin American Historic Review for Clinical Nutrition Products by Geographic Region - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 153: Latin American 14-Year Perspective for Clinical Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for Brazil, Mexico and Rest of Latin America Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 154: Latin American Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 155: Latin American Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 156: Latin American 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

7a. BRAZIL

  • Market Analysis
    • Table 157: Brazilian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 158: Brazilian Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 159: Brazilian 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

7b. MEXICO

  • Market Analysis
    • Table 160: Mexican Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 161: Mexican Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 162: Mexican 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

7c. REST OF LATIN AMERICA

  • A. Market Analysis
    • Current and Future Analysis
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 163: Rest of Latin America Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 164: Rest of Latin America Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 165: Rest of Latin America 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top